Good Manufacturing Practices for Asia/Pacific Pharmaceutical Companies – Accelerating Transformation with Manufacturing 4.0
We are pleased to share our NEW Research Paper titled ‘Good Manufacturing Practices for Asia/Pacific Pharmaceutical Companies – Accelerating Transformation with Manufacturing 4.0’, written by IDC with contributions from our colleagues. This paper includes:
-An overview of the Asia/Pacific pharmaceutical marketplace
-Key technologies to enable Manufacturing 4.0 in Asia
-Future outlook – short and long term benefits of digital transformation
-Building a roadmap – integrating the Factory of the Future
-Major pharma case study – delivering Full Manufacturing 4.0 Technology Stack
👇 Read this IDC paper to learn about use cases to help our customers draw a Manufacturing 4.0 roadmap that allows them to build on these foundational technologies to develop a strategic vision that creates a sustainable and competitive future enterprise.